Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 24 Jul 2026 for Savara Inc.
Filing timeline
BuySaleRobert Matthew Lutz
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Robert Matthew Lutz: trading record in brief
Robert Matthew Lutz is a declared insider at 3 companies (board member); the most frequent names are Savara Inc, iBio, Inc. and Strongbridge Biopharma plc. In total, 11 filings cover trades dated from 7 January 2021 to 15 July 2026.
Sales make up the whole of the open-market record (1 sale, €7,685). Besides market trades, the filings include 10 share grants.
On 24 July 2026 came the latest disclosure, a share grant in Savara Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert Matthew Lutz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
35,000 shares0Common StockSEC:0001193125-26-316442:0
67,760 shares@ US$6.92100.0% of flowCommon StockSEC:0001193125-25-321182:0
38,263 shares@ US$2.83100.0% of flowCommon StockSEC:0000950170-25-021312:0
100,000 shares0Common StockSEC:0000950170-24-136790:0
160,000 shares0Common StockSEC:0001209191-23-058854:0
140,000 shares0Common StockSEC:0001209191-23-013677:0
100,057 shares0Common StockSEC:0001104659-22-118975:0
24,625 shares@ US$0.3456100.0% of flowCommon StockSEC:0001104659-22-033320:0
8 of 8 declarations
